2008: Spondylarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology and Animal Models
Search or Browse by Day

Spondylarthropathies and Psoriatic Arthritis: Pathogenesis, Etiology and Animal Models

Sunday, October 26, 2008
483
DKK-1 Levels are Comparably Increased in Patients with AS and RA, Show Similar Decreases with Anti-TNF Therapy, and are not Associated with Markers of Bone Remodeling
484
Suppression Of Bone Morphogenetic Proteins Attenuates Syndesmophytosis By Down-regulating Smad Pathway In Aggrecan-induced Spondylitis Mice
485
HLA-B27 Transgenic Rat OX62+ DCs Exhibit Multiple Cellular Deficiencies and the Tolerigenic CD4- Subset Suffers Reduced Viability
486
Association of Adhesion Molecules (PECAM-1, ITGB1) Genes Polymorphisms with Uveitis in Ankylosing Spondylitis
487
Anterior Uveitis Accompanies Joint Disease in a Murine Model of Ankylosing Spondylitis
488
Deletion of Frizzled Related Protein (Frzb) reduces Severity of Ankylosis in a Mouse Model of Spondyloarthritis
489
Etanercept Attenuates Peripheral Inflammation, But Does Not Retard Inflammation Induced Ankylosis, In A Mouse Model Of Ankylosing Spondylitis
490
The Role of RANKL/OPG in the Pathogenesis of Peripheral Joint Bone Destruction of Ankylosing Spondylitis
491
Microarrays Identify A "regulator of G-protein signaling" As A Sensitive and Specific Spondyloarthritis (SpA) Biomarker
492
Association Of IL23r With As Genetic Susceptibility And Inflammation Related With Elevated Expression Of IL-23 And IL-17 In Chinese Population
493
Heterogeneous MicroRNA Pattern of AS Patients: Elevated Mir-27a as a new Biomarker Significantly Downregulated by Enbrel Treatment
494
Serum Dickkopf-1 (DKK-1) is unrelated to radiographic severity in Ankylosing Spondylitis
495
Peripheral Blood Gene Expression Profiles in Ankylosing Spondylitis: A Comparison to Healthy Controls, Systemic Sclerosis, and Systemic Lupus Erythematosus
496
Investigation Of Crohn’s Disease And Ankylosing Spondylitis Susceptibility Loci With Psoriatic Arthritis
497
Distinct Proteomic profile in Ankylosing Spondylitis Patients: Talin1 is a New Valuable Biomarker for diagnosis and treatment
498
In Situ Detection of IL-17 Secreting Cells in the Bone Marrow of Facet Joints Obtained from Patients with Ankylosing Spondylitis
499
Serum Levels of Biomarkers of New Vessel Formation, Bone Destruction and New Bone Formation in AS Patients Treated with and without Adalimumab: Possible Implications for the Sequence of Events
500
ARTS1 Gene Polymorphisms are Associated with Ankylosing Spondylitis in Koreans
501
Association of STAT4 variants and Ankylosing Spondylitis (AS)
502
Phenotypic And Functional Features Of Th-17 Cells In Psoriasis And Psoriatic Arthritis
503
Nerve Growth Factor And Its Receptor System In The Pathophysiology Of Synovial Tissue
504
Fine Mapping of Interleukin-23R in Ankylosing Spondylitis
505
Association of IRF5 polymorphisms in Psoriatic Arthritis
506
Two Synonymous SNPs in ARTS1 Are Associated with Ankylosing Spondylitis in Chinese Population
507
Family Based Association Analysis Confirms a Role for ARTS1 in Ankylosing Spondylitis but the Candidate Exonic Variant K528R is Not Related to Cytokine Receptor Shedding Profiles
508
Soluble LIGHT: a Novel Cytokine in Spondyloarthritis
509
Increased Frequency Of Mefv Gene Exon 10 Mutations In Patients With Ankylosing Spondylitis
See more of: ACR Abstract Submission Poster Sessions
<< Previous Session Level | Next Session Level >>